Ford Verity J, Applefeld Willard N, Wang Jeffrey, Sun Junfeng, Solomon Steven B, Klein Harvey G, Feng Jing, Lertora Juan, Parizi-Torabi Parizad, Danner Robert L, Solomon Michael A, Chen Marcus Y, Natanson Charles
Critical Care Medicine Department, Clinical Center, National Institutes of Health, (NIH, CC) Bethesda, Maryland 20892 USA.
Division of Cardiology, Duke University Medical Center, Durham, NC, USA.
bioRxiv. 2024 Feb 8:2024.02.05.578927. doi: 10.1101/2024.02.05.578927.
High levels of catecholamines are cardiotoxic and associated with stress-induced cardiomyopathies. Septic patients are routinely exposed to endogenously released and exogenously administered catecholamines, which may alter cardiac function and perfusion causing ischemia. Early during human septic shock, left ventricular ejection fraction (LVEF) decreases but normalizes in survivors over 7-10 days. Employing a septic shock model that reproduces these human septic cardiac findings, we investigated the effects of catecholamines on microcirculatory perfusion and cardiac function.
Purpose-bred beagles received intrabronchial (n=30) or saline (n=6) challenges and septic animals recieved either epinephrine (1mcg/kg/min, n=15) or saline (n=15) infusions from 4 to 44 hours. Serial cardiac magnetic resonance imaging (CMR), invasive hemodynamics and laboratory data including catecholamine levels and troponins were collected over 92 hours. Adenosine-stress perfusion CMR was performed on eight of the fifteen septic epinephrine, and eight of the fifteen septic saline animals. High-dose sedation was titrated for comfort and suppress endogenous catecholamine release.
Catecholamine levels were largely within the normal range throughout the study in animals receiving an intrabronchial bacteria or saline challenge. However, septic non-septic animals developed significant worsening of LV; EF, strain, and -aortic coupling that was not explained by differences in afterload, preload, or heart rate. In septic animals that received epinephrine saline infusions, plasma epinephrine levels increased 800-fold, pulmonary and systemic pressures significantly increased, and cardiac edema decreased. Despite this, septic animals receiving epinephrine saline during and after infusions, had no significant further worsening of LV; EF, strain, or -aortic coupling. Animals receiving saline had a sepsis-induced increase in microcirculatory reserve without troponin elevations. In contrast, septic animals receiving epinephrine had blunted microcirculatory perfusion and elevated troponin levels that persisted for hours after the infusion stopped. During infusion, septic animals that received epinephrine saline had significantly greater lactate, creatinine, and alanine aminotransferase levels.
Cardiac dysfunction during sepsis is not primarily due to elevated endogenous or exogenous catecholamines nor is it principally due to decreased microvascular perfusion-induced ischemia. However, epinephrine itself has potentially harmful long lasting ischemic effects during sepsis including impaired microvascular perfusion that persists after stopping the infusion.
高水平的儿茶酚胺具有心脏毒性,并与应激性心肌病相关。脓毒症患者经常暴露于内源性释放和外源性给予的儿茶酚胺中,这可能会改变心脏功能和灌注,导致缺血。在人类脓毒症休克早期,左心室射血分数(LVEF)会降低,但在7 - 10天内幸存者的LVEF会恢复正常。我们采用一种能再现这些人类脓毒症心脏表现的脓毒症休克模型,研究了儿茶酚胺对微循环灌注和心脏功能的影响。
特定品种的比格犬接受支气管内(n = 30)或生理盐水(n = 6)激发,脓毒症动物在4至44小时内接受肾上腺素(1μg/kg/min,n = 15)或生理盐水(n = 15)输注。在92小时内收集系列心脏磁共振成像(CMR)、有创血流动力学和实验室数据,包括儿茶酚胺水平和肌钙蛋白。对15只接受肾上腺素输注的脓毒症动物中的8只,以及15只接受生理盐水输注的脓毒症动物中的8只进行腺苷负荷灌注CMR检查。根据舒适度调整高剂量镇静剂以抑制内源性儿茶酚胺释放。
在接受支气管内细菌或生理盐水激发的动物中,整个研究过程中儿茶酚胺水平大多在正常范围内。然而,脓毒症和非脓毒症动物的左心室射血分数、应变和主动脉耦合均出现显著恶化,这不能用后负荷、前负荷或心率的差异来解释。在接受肾上腺素或生理盐水输注的脓毒症动物中,血浆肾上腺素水平增加了800倍,肺和全身压力显著升高,心脏水肿减轻。尽管如此,在输注期间和之后接受肾上腺素或生理盐水的脓毒症动物,其左心室射血分数、应变或主动脉耦合并无进一步显著恶化。接受生理盐水的动物脓毒症诱导的微循环储备增加,且肌钙蛋白未升高。相比之下,接受肾上腺素的脓毒症动物微循环灌注减弱,肌钙蛋白水平升高,且在输注停止后数小时仍持续升高。在输注期间,接受肾上腺素或生理盐水的脓毒症动物的乳酸、肌酐和丙氨酸转氨酶水平显著更高。
脓毒症期间的心脏功能障碍并非主要由于内源性或外源性儿茶酚胺升高,也不是主要由于微血管灌注减少导致的缺血。然而,肾上腺素本身在脓毒症期间具有潜在有害的长期缺血效应,包括在输注停止后仍持续存在的微血管灌注受损。